The estimated Net Worth of Eric Benjamin is at least $5.11 Million dollars as of 23 July 2020. Mr. Benjamin owns over 14,912 units of Insulet stock worth over $1,982,162 and over the last 7 years he sold PODD stock worth over $3,131,520. In addition, he makes $0 as Senior Vice President and Innovation and Strategy at Insulet.
Eric has made over 1 trades of the Insulet stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 14,912 units of PODD stock worth $3,131,520 on 23 July 2020.
The largest trade he's ever made was selling 14,912 units of Insulet stock on 23 July 2020 worth over $3,131,520. On average, Eric trades about 648 units every 0 days since 2018. As of 23 July 2020 he still owns at least 8,704 units of Insulet stock.
You can see the complete history of Mr. Benjamin stock trades at the bottom of the page.
Eric Benjamin serves as Senior Vice President, Innovation and Strategy of the Company. Mr. Benjamin has served as our Senior Vice President, Innovation and Strategy since February 2020. From February 2018 to January 2020, he served as Senior Vice President, R&D, New Product Development and Commercialization. From February 2016 to January 2018, he served as Vice President, Supplier Development, and from June 2015 to January 2016, Mr. Benjamin served as Director and Senior Director, Business Development. Prior to joining Insulet, from 2004 to 2012, Mr. Benjamin held roles of increasing responsibility spanning R&D, manufacturing and quality with Abbott Laboratories. From 2013 to May 2015, Mr. Benjamin attended Harvard Business School’s MBA program, from which he graduated with High Distinction. Mr. Benjamin holds a Bachelor of Science in Industrial Engineering and Operations Research from the University of California, Berkeley, a Master of Engineering in Bioengineering from the University of California, San Diego, and a Master of Business Administration from Harvard Business School.
Eric Benjamin is 37, he's been the Senior Vice President and Innovation and Strategy of Insulet since 2020. There are 22 older and no younger executives at Insulet. The oldest executive at Insulet Corporation is John Fallon, 72, who is the Independent Director.
Eric's mailing address filed with the SEC is C/O INSULET CORPORATION, 100 NAGOG PARK, ACTON, MA, 01720.
Over the last 18 years, insiders at Insulet have traded over $64,849,299 worth of Insulet stock and bought 175,262 units worth $7,280,516 . The most active insiders traders include Jonathan Silverstein, Elizabeth H Weatherman, and Samuel D Colella. On average, Insulet executives and independent directors trade stock every 19 days with the average trade being worth of $2,473,148. The most recent stock trade was executed by Timothy J Scannell on 10 September 2024, trading 5,000 units of PODD stock currently worth $1,129,200.
insulet corporation is an innovative medical device company based in billerica, massachusetts. it was founded in 2000 with the mission of improving the lives of people with diabetes. specifically, through its revolutionary omnipod insulin management system, insulet seeks to expand the use of insulin pump therapy. studies have demonstrated the advantages of insulin pump therapy over multiple daily insulin injections (mdi); these advantages include better glycemic control, fewer hypoglycemic events, reduced glycemic variability1 and improved quality of life2. despite these benefits, most people still choose mdi therapy largely due to the complexity, cost and inconvenience of conventional pump technology. the omnipod is a discreet and easy-to-use system that eliminates many of the issues associated with conventional pumps. improvements include omnipod's lack of tubing; automated, virtually pain-free insertion; and two straightforward parts that communicate wirelessly. by breaking down
Insulet executives and other stock owners filed with the SEC include: